Hi everyone welcome to the A6 and Z podcast I'm Sonil and today I'm sharing our

most recent Journal Club here. This particular episode is all about a safer

psychedelic. Yes you heard that right.

Before I tell you more about the topic, as many of you may recall, I announced our new

show Journal Club in this feed last year because we're all about bringing you new ideas

and how to translate them from theory to practice.

And it's now available as part of our show BioEats World.

So be sure to subscribe to that wherever you get your podcast

if you haven't already.

So now, let me quickly share more about this episode.

In recent years there's been a shift in how we think about psychedelics from drugs

of abuse and recreation to powerful drugs for treating neuropsychiatric conditions such as depression,

addiction and PTSD. But there's still a lot we don't know about how they work and how we can

maximize their therapeutic benefits while

minimizing their adverse side effects. So this episode of Journal Club

discusses a paper published in nature last month on a method for striking the balance between these benefits and

side effects which could represent a major step forward in psychedelic medicine.

Hi I'm Hannah and I'm Lauren and this is the BioEats World Journal Club, where every Thursday we discuss

breakthrough scientific research, the new opportunities it presents, and how to take it from paper

to practice.

And today, we're talking about one possible path to

take psychedelic drugs from the lab and into the clinic. So Lauren are we talking

...